Injectsense
Iqbal "Ike" Ahmed, MD, FRCSC, is recognized globally for his skills and groundbreaking work in the diagnosis and surgical treatment of highly complex eye diseases including glaucoma and surgical complications. As research director and professor at the Kensington Eye Institute at the University of Toronto, he is acknowledged as one of the most experienced complex eye surgeons in the world and has trained numerous surgeons in innovative surgical techniques. He has been at the leading edge of novel treatments for glaucoma, cataract and lens implant surgery, with a focus on “micro-invasive glaucoma surgery” (MIGS), a medical domain and term that he developed.
This person is not in the org chart
This person is not in any offices
Injectsense
Injectsense enables tracking of progressive disease indicators and improved therapy management by providing continuous, clinically actionable information through an injectable ultra-miniature sensor coupled with a secure digital health platform.